Market Overview:
The global HIV test kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of HIV/AIDS, growing awareness about HIV testing, and technological advancements in HIV test kits. The global HIV test kits market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibody tests, RNA (viral load) tests, and antibody-antigen tests. The antibody tests segment dominates the global HIV test kit market owing to their high accuracy and reliability for detecting antibodies against human immunodeficiency virus (HIV). On the basis of application, diagnostic centers account for a major share of the global HIV test kit market followed by hospitals and home users. The growth in this segment can be attributed to rising demand for early diagnosis and treatment options for AIDS patients across different geographies.
Product Definition:
HIV Test Kits are used to detect the presence of HIV antibodies in a person's blood. They are an important tool in the prevention and diagnosis of HIV/AIDS.
Antibody Tests:
Antibody tests are used for the detection of antibodies in the blood. These tests are also known as immunoassays or serological testing. The test works by detecting a specific antibody present in the blood sample which is reacting with an antigen (HIV-1). HIV antibody tests have been available since 1983 and have undergone various changes over time to improve its specificity, sensitivity, and accuracy.
RNA (viral load) Test:
The RNA (viral load) test is used to measure the amount of viral RNA in a sample. Viral load tests are used for HIV diagnostics as they provide accurate results and help detect low levels of virus that may not be able to be detected by visual inspection.
Application Insights:
The diagnostic centers segment dominated the global HIV test kits market in 2017. This is attributed to factors such as availability of a large number of testing facilities, high prevalence of HIV and increasing awareness among individuals regarding early diagnosis. Furthermore, an increase in the adoption of self-testing products is also expected to boost growth over the forecast period. For instance, according to data published by UNAIDS, around 37%of people living with AIDS (PWAs) have been found to be accessing prevention services since 2013 globally.
Hospitals are anticipated to witness significant growth over the forecast period due largelyto rising incidence rates and expanding treatment facilities for patients suffering from AIDS-related complex diseases or acquired immune deficiency syndrome (AIDS).
Regional Analysis:
North America dominated the global HIV test kits market in 2017. The presence of sophisticated healthcare infrastructure, high awareness levels coupled with relatively higher disposable income and better access to health services are some of the factors responsible for its large share. Moreover, government initiatives such as PEPFAR that support antiretroviral therapy for patients suffering from HIV/AIDS is expected to boost demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to a rise in prevalence rates of infectious diseases such as HIV and Ebola virus disease (EVD). According to WHO, an estimated 36 million people were living with HIV-1 in Asia at year 2016; this number is projecteded reach 60 million by 2026. In addition, increasing cases of EVD have also led Asia Pacific countries like India and China where there are around 3 million people living with Hiv-1 who will be susceptible during epidemic outbreaks thus creating opportunities for manufacturers operating within this region.
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is on the rise, with an estimated 36.7 million people living with the virus in 2017. This is expected to drive demand for HIV test kits over the forecast period.
- Growing awareness about AIDS and its prevention: There is a growing awareness about AIDS and its prevention among people across the world, which is likely to boost demand for HIV test kits in the coming years.
- Technological advancements in diagnostic tests: Rapid advances in diagnostic technologies are helping to improve accuracy and speed of diagnosis for various diseases, including HIV/AIDS. This is likely to spur growth prospects for the global HIV test kit market over the forecast period.
- . 5 Rising number of testing centers: The number of authorized testing centers providing services for detection of human immunodeficiency virus (HIV) infection has been increasing globally, thereby propelling growth prospectsfortheglobalHIVtestkitmarketduring2018-2024
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Test Kits Market Research Report
By Type
Antibody Tests, RNA (viral load) Test, Antibody-antigen Test
By Application
Diagnostic Centers, Hospitals, Home Use
By Companies
Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon, Intec, ThermoFisher, Biokit, Nectar Lifesciences, ELITech Group, Chembio Diagnostic Systems, Trinity Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global HIV Test Kits Market Report Segments:
The global HIV Test Kits market is segmented on the basis of:
Types
Antibody Tests, RNA (viral load) Test, Antibody-antigen Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Home Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Bio-Rad
- WanTai BioPharm
- Beckman Coulter
- BD
- Kehua
- Livzon
- Intec
- ThermoFisher
- Biokit
- Nectar Lifesciences
- ELITech Group
- Chembio Diagnostic Systems
- Trinity Biotech
Highlights of The HIV Test Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody Tests
- RNA (viral load) Test
- Antibody-antigen Test
- By Application:
- Diagnostic Centers
- Hospitals
- Home Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Test Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV test kits are a type of laboratory equipment used to detect the presence of HIV in blood, semen, or other body fluids.
Some of the major players in the hiv test kits market are Roche, Abbott, Bio-Rad, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon, Intec, ThermoFisher, Biokit, Nectar Lifesciences, ELITech Group, Chembio Diagnostic Systems, Trinity Biotech.
The hiv test kits market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV Test Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV Test Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV Test Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV Test Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV Test Kits Market Size & Forecast, 2020-2028
4.5.1 HIV Test Kits Market Size and Y-o-Y Growth
4.5.2 HIV Test Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibody Tests
5.2.2 RNA (viral load) Test
5.2.3 Antibody-antigen Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostic Centers
6.2.2 Hospitals
6.2.3 Home Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV Test Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV Test Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibody Tests
9.6.2 RNA (viral load) Test
9.6.3 Antibody-antigen Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostic Centers
9.10.2 Hospitals
9.10.3 Home Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibody Tests
10.6.2 RNA (viral load) Test
10.6.3 Antibody-antigen Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostic Centers
10.10.2 Hospitals
10.10.3 Home Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibody Tests
11.6.2 RNA (viral load) Test
11.6.3 Antibody-antigen Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostic Centers
11.10.2 Hospitals
11.10.3 Home Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibody Tests
12.6.2 RNA (viral load) Test
12.6.3 Antibody-antigen Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostic Centers
12.10.2 Hospitals
12.10.3 Home Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibody Tests
13.6.2 RNA (viral load) Test
13.6.3 Antibody-antigen Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostic Centers
13.10.2 Hospitals
13.10.3 Home Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV Test Kits Market: Competitive Dashboard
14.2 Global HIV Test Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott
14.3.3 Bio-Rad
14.3.4 WanTai BioPharm
14.3.5 Beckman Coulter
14.3.6 BD
14.3.7 Kehua
14.3.8 Livzon
14.3.9 Intec
14.3.10 ThermoFisher
14.3.11 Biokit
14.3.12 Nectar Lifesciences
14.3.13 ELITech Group
14.3.14 Chembio Diagnostic Systems
14.3.15 Trinity Biotech
